 | • レポートコード：GIR-107A14560 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、フリードライヒ運動失調症薬治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フリードライヒ運動失調症薬治療薬の種類別市場規模（ADVM-063、 AGIL-FA、 BHV-4157、 BVA-202、その他）、用途別市場規模（クリニック、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・フリードライヒ運動失調症薬治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Adverum Biotechnologies Inc、BioMarin Pharmaceutical Inc.、Biovista Inc.、Cardero Therapeutics Inc、Catabasis Pharmaceuticals, Inc.、Forward Pharma A/S、Ixchel Pharma LLC、Pfizer Inc、ProQR Therapeutics NV、RaNA Therapeutics Inc、Reata Pharmaceuticals Inc、Retrotope Inc、Takeda、STATegics Inc、Voyager Therapeutics Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ADVM-063、 AGIL-FA、 BHV-4157、 BVA-202、その他 ・用途別分析2016年-2026年：クリニック、病院、その他 ・フリードライヒ運動失調症薬治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・フリードライヒ運動失調症薬治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・フリードライヒ運動失調症薬治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フリードライヒ運動失調症薬治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・フリードライヒ運動失調症薬治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Friedreich Ataxia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Friedreich Ataxia Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Friedreich Ataxia Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Friedreich Ataxia Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Market segment by Application can be divided into
Clinic
Hospital
Others
The key market players for global Friedreich Ataxia Drug market are listed below:
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Takeda
STATegics Inc
Voyager Therapeutics Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Friedreich Ataxia Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Friedreich Ataxia Drug, with price, sales, revenue and global market share of Friedreich Ataxia Drug from 2019 to 2021.
Chapter 3, the Friedreich Ataxia Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Friedreich Ataxia Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Friedreich Ataxia Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Friedreich Ataxia Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Friedreich Ataxia Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Friedreich Ataxia Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 ADVM-063
1.2.3 AGIL-FA
1.2.4 BHV-4157
1.2.5 BVA-202
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Friedreich Ataxia Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Friedreich Ataxia Drug Market Size & Forecast
1.4.1 Global Friedreich Ataxia Drug Sales in Value (2016-2026))
1.4.2 Global Friedreich Ataxia Drug Sales in Volume (2016-2026)
1.4.3 Global Friedreich Ataxia Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Friedreich Ataxia Drug Production Capacity Analysis
1.5.1 Global Friedreich Ataxia Drug Total Production Capacity (2016-2026)
1.5.2 Global Friedreich Ataxia Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Friedreich Ataxia Drug Market Drivers
1.6.2 Friedreich Ataxia Drug Market Restraints
1.6.3 Friedreich Ataxia Drug Trends Analysis
2 Manufacturers Profiles
2.1 Adverum Biotechnologies Inc
2.1.1 Adverum Biotechnologies Inc Details
2.1.2 Adverum Biotechnologies Inc Major Business
2.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product and Services
2.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 BioMarin Pharmaceutical Inc.
2.2.1 BioMarin Pharmaceutical Inc. Details
2.2.2 BioMarin Pharmaceutical Inc. Major Business
2.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product and Services
2.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Biovista Inc.
2.3.1 Biovista Inc. Details
2.3.2 Biovista Inc. Major Business
2.3.3 Biovista Inc. Friedreich Ataxia Drug Product and Services
2.3.4 Biovista Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cardero Therapeutics Inc
2.4.1 Cardero Therapeutics Inc Details
2.4.2 Cardero Therapeutics Inc Major Business
2.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Product and Services
2.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Catabasis Pharmaceuticals, Inc.
2.5.1 Catabasis Pharmaceuticals, Inc. Details
2.5.2 Catabasis Pharmaceuticals, Inc. Major Business
2.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product and Services
2.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Forward Pharma A/S
2.6.1 Forward Pharma A/S Details
2.6.2 Forward Pharma A/S Major Business
2.6.3 Forward Pharma A/S Friedreich Ataxia Drug Product and Services
2.6.4 Forward Pharma A/S Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Ixchel Pharma LLC
2.7.1 Ixchel Pharma LLC Details
2.7.2 Ixchel Pharma LLC Major Business
2.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Product and Services
2.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer Inc
2.8.1 Pfizer Inc Details
2.8.2 Pfizer Inc Major Business
2.8.3 Pfizer Inc Friedreich Ataxia Drug Product and Services
2.8.4 Pfizer Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 ProQR Therapeutics NV
2.9.1 ProQR Therapeutics NV Details
2.9.2 ProQR Therapeutics NV Major Business
2.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Product and Services
2.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 RaNA Therapeutics Inc
2.10.1 RaNA Therapeutics Inc Details
2.10.2 RaNA Therapeutics Inc Major Business
2.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Product and Services
2.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Reata Pharmaceuticals Inc
2.11.1 Reata Pharmaceuticals Inc Details
2.11.2 Reata Pharmaceuticals Inc Major Business
2.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product and Services
2.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Retrotope Inc
2.12.1 Retrotope Inc Details
2.12.2 Retrotope Inc Major Business
2.12.3 Retrotope Inc Friedreich Ataxia Drug Product and Services
2.12.4 Retrotope Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Friedreich Ataxia Drug Product and Services
2.13.4 Takeda Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 STATegics Inc
2.14.1 STATegics Inc Details
2.14.2 STATegics Inc Major Business
2.14.3 STATegics Inc Friedreich Ataxia Drug Product and Services
2.14.4 STATegics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Voyager Therapeutics Inc
2.15.1 Voyager Therapeutics Inc Details
2.15.2 Voyager Therapeutics Inc Major Business
2.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Product and Services
2.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Friedreich Ataxia Drug Sales by Manufacturer
3.1 Global Friedreich Ataxia Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Friedreich Ataxia Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Friedreich Ataxia Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Friedreich Ataxia Drug Manufacturer Market Share
3.4.2 Top 6 Friedreich Ataxia Drug Manufacturer Market Share
3.5 Global Friedreich Ataxia Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Friedreich Ataxia Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Friedreich Ataxia Drug Market Size by Region
4.1.1 Global Friedreich Ataxia Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Friedreich Ataxia Drug Revenue by Region (2016-2026)
4.2 North America Friedreich Ataxia Drug Revenue (2016-2026)
4.3 Europe Friedreich Ataxia Drug Revenue (2016-2026)
4.4 Asia-Pacific Friedreich Ataxia Drug Revenue (2016-2026)
4.5 South America Friedreich Ataxia Drug Revenue (2016-2026)
4.6 Middle East and Africa Friedreich Ataxia Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Friedreich Ataxia Drug Sales in Volume by Type (2016-2026)
5.2 Global Friedreich Ataxia Drug Revenue by Type (2016-2026)
5.3 Global Friedreich Ataxia Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Friedreich Ataxia Drug Sales in Volume by Application (2016-2026)
6.2 Global Friedreich Ataxia Drug Revenue by Application (2016-2026)
6.3 Global Friedreich Ataxia Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Friedreich Ataxia Drug Sales by Type (2016-2026)
7.2 North America Friedreich Ataxia Drug Sales by Application (2016-2026)
7.3 North America Friedreich Ataxia Drug Market Size by Country
7.3.1 North America Friedreich Ataxia Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Friedreich Ataxia Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Friedreich Ataxia Drug Sales by Type (2016-2026)
8.2 Europe Friedreich Ataxia Drug Sales by Application (2016-2026)
8.3 Europe Friedreich Ataxia Drug Market Size by Country
8.3.1 Europe Friedreich Ataxia Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Friedreich Ataxia Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Friedreich Ataxia Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Friedreich Ataxia Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Friedreich Ataxia Drug Market Size by Region
9.3.1 Asia-Pacific Friedreich Ataxia Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Friedreich Ataxia Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Friedreich Ataxia Drug Sales by Type (2016-2026)
10.2 South America Friedreich Ataxia Drug Sales by Application (2016-2026)
10.3 South America Friedreich Ataxia Drug Market Size by Country
10.3.1 South America Friedreich Ataxia Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Friedreich Ataxia Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Friedreich Ataxia Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Friedreich Ataxia Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Friedreich Ataxia Drug Market Size by Country
11.3.1 Middle East & Africa Friedreich Ataxia Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Friedreich Ataxia Drug Typical Distributors
12.3 Friedreich Ataxia Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Friedreich Ataxia Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Friedreich Ataxia Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Adverum Biotechnologies Inc Basic Information, Manufacturing Base and Competitors
Table 4. Adverum Biotechnologies Inc Major Business
Table 5. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product and Services
Table 6. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BioMarin Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 8. BioMarin Pharmaceutical Inc. Major Business
Table 9. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product and Services
Table 10. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biovista Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Biovista Inc. Major Business
Table 13. Biovista Inc. Friedreich Ataxia Drug Product and Services
Table 14. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cardero Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 16. Cardero Therapeutics Inc Major Business
Table 17. Cardero Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 18. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Catabasis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Catabasis Pharmaceuticals, Inc. Major Business
Table 21. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product and Services
Table 22. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Forward Pharma A/S Basic Information, Manufacturing Base and Competitors
Table 24. Forward Pharma A/S Major Business
Table 25. Forward Pharma A/S Friedreich Ataxia Drug Product and Services
Table 26. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Ixchel Pharma LLC Basic Information, Manufacturing Base and Competitors
Table 28. Ixchel Pharma LLC Major Business
Table 29. Ixchel Pharma LLC Friedreich Ataxia Drug Product and Services
Table 30. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Inc Major Business
Table 33. Pfizer Inc Friedreich Ataxia Drug Product and Services
Table 34. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. ProQR Therapeutics NV Basic Information, Manufacturing Base and Competitors
Table 36. ProQR Therapeutics NV Major Business
Table 37. ProQR Therapeutics NV Friedreich Ataxia Drug Product and Services
Table 38. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. RaNA Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 40. RaNA Therapeutics Inc Major Business
Table 41. RaNA Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 42. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Reata Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 44. Reata Pharmaceuticals Inc Major Business
Table 45. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product and Services
Table 46. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Retrotope Inc Basic Information, Manufacturing Base and Competitors
Table 48. Retrotope Inc Major Business
Table 49. Retrotope Inc Friedreich Ataxia Drug Product and Services
Table 50. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Takeda Basic Information, Manufacturing Base and Competitors
Table 52. Takeda Major Business
Table 53. Takeda Friedreich Ataxia Drug Product and Services
Table 54. Takeda Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. STATegics Inc Basic Information, Manufacturing Base and Competitors
Table 56. STATegics Inc Major Business
Table 57. STATegics Inc Friedreich Ataxia Drug Product and Services
Table 58. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Voyager Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 60. Voyager Therapeutics Inc Major Business
Table 61. Voyager Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 62. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Friedreich Ataxia Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 64. Global Friedreich Ataxia Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Friedreich Ataxia Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Friedreich Ataxia Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 67. Head Office and Friedreich Ataxia Drug Production Site of Key Manufacturer
Table 68. Friedreich Ataxia Drug New Entrant and Capacity Expansion Plans
Table 69. Friedreich Ataxia Drug Mergers & Acquisitions in the Past Five Years
Table 70. Global Friedreich Ataxia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 71. Global Friedreich Ataxia Drug Sales by Region (2021-2026) & (K Pcs)
Table 72. Global Friedreich Ataxia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Friedreich Ataxia Drug Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Friedreich Ataxia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 75. Global Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Pcs)
Table 76. Global Friedreich Ataxia Drug Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Friedreich Ataxia Drug Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Friedreich Ataxia Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 79. Global Friedreich Ataxia Drug Price by Type (2021-2026) & (USD/Pcs)
Table 80. Global Friedreich Ataxia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 81. Global Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Pcs)
Table 82. Global Friedreich Ataxia Drug Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Friedreich Ataxia Drug Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Friedreich Ataxia Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 85. Global Friedreich Ataxia Drug Price by Application (2021-2026) & (USD/Pcs)
Table 86. North America Friedreich Ataxia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 87. North America Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Pcs)
Table 88. North America Friedreich Ataxia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Friedreich Ataxia Drug Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Friedreich Ataxia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. North America Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. North America Friedreich Ataxia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. North America Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. Europe Friedreich Ataxia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 95. Europe Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Pcs)
Table 96. Europe Friedreich Ataxia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Friedreich Ataxia Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Friedreich Ataxia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 99. Europe Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Pcs)
Table 100. Europe Friedreich Ataxia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 101. Europe Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Pcs)
Table 102. Asia-Pacific Friedreich Ataxia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Friedreich Ataxia Drug Sales by Region (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Friedreich Ataxia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Friedreich Ataxia Drug Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Friedreich Ataxia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 107. Asia-Pacific Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Pcs)
Table 108. Asia-Pacific Friedreich Ataxia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 109. Asia-Pacific Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Pcs)
Table 110. South America Friedreich Ataxia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 111. South America Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Pcs)
Table 112. South America Friedreich Ataxia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Friedreich Ataxia Drug Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Friedreich Ataxia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 115. South America Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Pcs)
Table 116. South America Friedreich Ataxia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 117. South America Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Pcs)
Table 118. Middle East & Africa Friedreich Ataxia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Friedreich Ataxia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 123. Middle East & Africa Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Pcs)
Table 124. Middle East & Africa Friedreich Ataxia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 125. Middle East & Africa Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Pcs)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Friedreich Ataxia Drug Typical Distributors
Table 129. Friedreich Ataxia Drug Typical Customers
List of Figures
Figure 1. Friedreich Ataxia Drug Picture
Figure 2. Global Friedreich Ataxia Drug Sales Market Share by Type in 2020
Figure 3. ADVM-063
Figure 4. AGIL-FA
Figure 5. BHV-4157
Figure 6. BVA-202
Figure 7. Others
Figure 8. Global Friedreich Ataxia Drug Sales Market Share by Application in 2020
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Friedreich Ataxia Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Friedreich Ataxia Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Friedreich Ataxia Drug Sales (2016-2026) & (K Pcs)
Figure 15. Global Friedreich Ataxia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Friedreich Ataxia Drug Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Friedreich Ataxia Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Friedreich Ataxia Drug Market Drivers
Figure 19. Friedreich Ataxia Drug Market Restraints
Figure 20. Friedreich Ataxia Drug Market Trends
Figure 21. Global Friedreich Ataxia Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Friedreich Ataxia Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Friedreich Ataxia Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Friedreich Ataxia Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Friedreich Ataxia Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Friedreich Ataxia Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Friedreich Ataxia Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Friedreich Ataxia Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Friedreich Ataxia Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Friedreich Ataxia Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Friedreich Ataxia Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Friedreich Ataxia Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Friedreich Ataxia Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Friedreich Ataxia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Friedreich Ataxia Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Friedreich Ataxia Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Friedreich Ataxia Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Friedreich Ataxia Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Friedreich Ataxia Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Friedreich Ataxia Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Friedreich Ataxia Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Friedreich Ataxia Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Friedreich Ataxia Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Friedreich Ataxia Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Friedreich Ataxia Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Friedreich Ataxia Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Friedreich Ataxia Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Friedreich Ataxia Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Friedreich Ataxia Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Friedreich Ataxia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の甲状腺機能低下症治療薬市場 2021：企業別、地域別、種類・用途別 The Hypothyroidism Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界のゴセレリン薬市場 2021：企業別、地域別、種類・用途別 The Goserelin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の薬物乱用検査サービス市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のレノックス・ガストー症候群治療薬市場 2021：企業別、地域別、種類・用途別 The Lennox-Gastaut Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の緑膿菌肺炎治療薬市場 2021：企業別、地域別、種類・用途別 The Pseudomonas Aeruginosa Pneumonia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…